This week in aesthetics, we highlight baricitinib for hair regrowth in alopecia areata patients, the April “Meet the Aesthetic Expert” column, and more.
Eli Lilly and Incyte announce results from its phase 3 study evaluating baricitinib 2 mg and 4 mg for the treatment of alopecia areata, making it the first phase 3 study with top-line results in patients with the hair disorder.
This week in aesthetics, we highlight hair transplantation devices, laser technology purchases, and more.
Neil Sadick, MD, discusses updates in hair transplant devices, the evolution of achieving natural-looking restoration results, along with robotic and non-robotic techniques.
The AAD recently announced it will soon begin accepting applications for its 2021 Hair Loss and Alopecia Initiative in Research (HAIR) Grant Program, which focuses on funding research for hair disorders, especially in diverse populations.